Organization
Georgetown University Hospital, Washington, DC
3 abstracts
Abstract
Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.Org: Alliance Statistics and Data Management Center, Rochester, MN, University of Chicago, Chicago, IL, Georgetown University Hospital, Washington, DC, Helen F. Graham Cancer Center and Research Institute, Newark, DE, University of North Carolina, Chapel Hill, NC,
Abstract
Phase 1 study of WNT pathway Porcupine inhibitor CGX1321 and phase 1b study of CGX1321 + pembrolizumab (pembro) in patients (pts) with advanced gastrointestinal (GI) tumors.Org: Dana-Farber Cancer Institute, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, Georgetown University Hospital, Washington, DC, Lombardi Comprehensive Cancer Center, START San Antonio,
Abstract
ANGIOGRAPHIC PROGRESSION OF DISEASE IN LARGE-VESSEL VASCULITISOrg: National Institutes of Health All of Us Research Program, Georgetown University Hospital, Washington, DC,